By Tom Jackson
Nigerian genomics research, services and development startup 54gene has launched a US$500,000 fund to tackle the current challenges around testing for COVID-19 in the country.
Founded in 2019 by Dr Abasi Ene-Obong, 54gene utilises human genetic data to improve the development, availability and efficacy of medical products that will prove beneficial to Africans and the wider global population.
54gene opened the fund by donating US$150,000, and within 24 hours secured an additional US$350,000 from partners including Union Bank. The money raised will help increase COVID-19 testing capacity in Nigeria by up to 1,000 additional tests a day, by buying testing instruments and the required biosafety materials such as biosafety cabinets and personal protective equipment needed to keep frontline healthcare workers safe.
Ongoing discussions with other Nigerian institutions are currently taking place, as the company looks to raise enough to accelerate and expand to up to 5,000 tests per day. By intensifying the testing process for COVID-19, 54gene and funding partners plan to help minimise Click here to read entire article